TAIDOC TECHNOLOGY CORP Net Assets
TAIDOC TECHNOLOGY CORP net assets. Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has net assets worth NT$9.96 Billion TWD (≈ $313.66 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$13.07 Billion ≈ $411.83 Million USD) and total liabilities (NT$3.12 Billion ≈ $98.17 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 4736 net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$9.96 Billion |
| % of Total Assets | 76.16% |
| Annual Growth Rate | 11.79% |
| 5-Year Change | 32.61% |
| 10-Year Change | 229.17% |
| Growth Volatility | 15.1 |
Net Assets of TAIDOC TECHNOLOGY CORP (2009–2025)
Net assets of TAIDOC TECHNOLOGY CORP from 2009 to 2025. This chart illustrates how TAIDOC TECHNOLOGY CORP's net assets have evolved over time, based on quarterly financial data. See net asset quality index of TAIDOC TECHNOLOGY CORP to measure how much of total assets are equity-financed.
Annual Net Assets for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual net assets of TAIDOC TECHNOLOGY CORP from 2009 to 2025. For live market cap and overall valuation, see market cap of TAIDOC TECHNOLOGY CORP.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | NT$10.12 Billion ≈ $318.98 Million |
+6.32% |
| 2024-09-30 | NT$9.52 Billion ≈ $300.01 Million |
+2.85% |
| 2023-09-30 | NT$9.26 Billion ≈ $291.71 Million |
-7.36% |
| 2022-09-30 | NT$9.99 Billion ≈ $314.89 Million |
+30.92% |
| 2021-09-30 | NT$7.63 Billion ≈ $240.53 Million |
+15.31% |
| 2020-09-30 | NT$6.62 Billion ≈ $208.59 Million |
+46.77% |
| 2019-09-30 | NT$4.51 Billion ≈ $142.12 Million |
+12.13% |
| 2018-09-30 | NT$4.02 Billion ≈ $126.75 Million |
+26.55% |
| 2017-09-30 | NT$3.18 Billion ≈ $100.15 Million |
+3.36% |
| 2016-09-30 | NT$3.08 Billion ≈ $96.90 Million |
+5.56% |
| 2015-09-30 | NT$2.91 Billion ≈ $91.80 Million |
+17.06% |
| 2014-09-30 | NT$2.49 Billion ≈ $78.42 Million |
+17.79% |
| 2013-09-30 | NT$2.11 Billion ≈ $66.57 Million |
+7.83% |
| 2012-09-30 | NT$1.96 Billion ≈ $61.74 Million |
-4.62% |
| 2011-09-30 | NT$2.05 Billion ≈ $64.73 Million |
-9.36% |
| 2010-09-30 | NT$2.27 Billion ≈ $71.41 Million |
+33.25% |
| 2009-09-30 | NT$1.70 Billion ≈ $53.59 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to TAIDOC TECHNOLOGY CORP's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 879.2% over the analyzed period, indicating profitable operations and earnings retention.
TAIDOC TECHNOLOGY CORP Net Assets Breakdown (September 2025)
TAIDOC TECHNOLOGY CORP net assets breakdown by equity component as of September 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$5.46 Billion | 55.85% |
| Common Stock | NT$953.74 Million | 9.75% |
| Other Components | NT$3.37 Billion | 34.41% |
| Total Equity | NT$9.79 Billion | 100.00% |
TAIDOC TECHNOLOGY CORP Competitors by Market Cap
The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Unipar Carbocloro S.A
SA:UNIP3
|
$382.25 Million |
|
Hamborner REIT AG
XETRA:HABA
|
$382.30 Million |
|
Beijing Jingxi Culture&Tourism Co Ltd
SHE:000802
|
$382.37 Million |
|
Impulse Qingdao Health Tech Co Ltd
SHE:002899
|
$382.37 Million |
|
Taiwan Steel Union Co Ltd
TW:6581
|
$382.12 Million |
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
$382.08 Million |
|
Thonburi Healthcare Grp Pcl
BK:THG
|
$382.00 Million |
|
Oxford Industries Inc
NYSE:OXM
|
$381.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TAIDOC TECHNOLOGY CORP's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,085,827,000 to 9,785,652,000, a change of 699,825,000 (7.7%).
- Net income of 1,441,815,000 contributed positively to equity growth.
- Dividend payments of 925,744,000 reduced retained earnings.
- Other factors increased equity by 183,754,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$1.44 Billion | +14.73% |
| Dividends Paid | NT$925.74 Million | -9.46% |
| Other Changes | NT$183.75 Million | +1.88% |
| Total Change | NT$- | 7.70% |
Book Value vs Market Value Analysis
This analysis compares TAIDOC TECHNOLOGY CORP's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.92x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-09-30 | NT$26.22 | NT$129.00 | x |
| 2010-09-30 | NT$33.20 | NT$129.00 | x |
| 2011-09-30 | NT$27.20 | NT$129.00 | x |
| 2012-09-30 | NT$26.50 | NT$129.00 | x |
| 2013-09-30 | NT$27.76 | NT$129.00 | x |
| 2014-09-30 | NT$30.60 | NT$129.00 | x |
| 2015-09-30 | NT$34.48 | NT$129.00 | x |
| 2016-09-30 | NT$35.95 | NT$129.00 | x |
| 2017-09-30 | NT$36.49 | NT$129.00 | x |
| 2018-09-30 | NT$46.34 | NT$129.00 | x |
| 2019-09-30 | NT$49.75 | NT$129.00 | x |
| 2020-09-30 | NT$68.96 | NT$129.00 | x |
| 2021-09-30 | NT$77.08 | NT$129.00 | x |
| 2022-09-30 | NT$100.30 | NT$129.00 | x |
| 2023-09-30 | NT$92.95 | NT$129.00 | x |
| 2024-09-30 | NT$94.90 | NT$129.00 | x |
| 2025-09-30 | NT$101.12 | NT$129.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TAIDOC TECHNOLOGY CORP utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.73%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 34.30%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 1.31x
- Recent ROE (14.73%) is below the historical average (17.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 25.58% | 18.91% | 0.80x | 1.70x | NT$243.75 Million |
| 2010 | 9.79% | 9.90% | 0.68x | 1.44x | NT$-4.41 Million |
| 2011 | 11.16% | 10.64% | 0.67x | 1.56x | NT$22.51 Million |
| 2012 | 8.71% | 6.69% | 0.79x | 1.65x | NT$-23.99 Million |
| 2013 | 17.01% | 14.87% | 0.72x | 1.58x | NT$141.25 Million |
| 2014 | 17.75% | 16.96% | 0.64x | 1.64x | NT$186.78 Million |
| 2015 | 15.71% | 16.88% | 0.61x | 1.53x | NT$161.83 Million |
| 2016 | 16.44% | 15.54% | 0.62x | 1.70x | NT$191.66 Million |
| 2017 | 13.93% | 12.71% | 0.55x | 1.99x | NT$119.97 Million |
| 2018 | 22.62% | 20.17% | 0.58x | 1.94x | NT$489.10 Million |
| 2019 | 15.20% | 16.04% | 0.53x | 1.79x | NT$226.98 Million |
| 2020 | 23.67% | 25.77% | 0.64x | 1.43x | NT$878.69 Million |
| 2021 | 26.72% | 30.42% | 0.62x | 1.42x | NT$1.24 Billion |
| 2022 | 34.99% | 35.14% | 0.75x | 1.33x | NT$2.42 Billion |
| 2023 | 11.43% | 21.17% | 0.40x | 1.34x | NT$127.28 Million |
| 2024 | 12.75% | 24.97% | 0.38x | 1.35x | NT$250.19 Million |
| 2025 | 14.73% | 34.30% | 0.33x | 1.31x | NT$463.25 Million |
Industry Comparison
This section compares TAIDOC TECHNOLOGY CORP's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,443,425,000
- Average return on equity (ROE) among peers: 9.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TAIDOC TECHNOLOGY CORP (4736) | NT$9.96 Billion | 25.58% | 0.31x | $382.20 Million |
| Hi-Clearance (1788) | $2.01 Billion | 15.76% | 1.09x | $178.14 Million |
| Radiant Innovation (3373) | $658.75 Million | 4.37% | 0.19x | $23.63 Million |
| Wellell Inc (4106) | $1.56 Billion | 7.86% | 0.66x | $75.35 Million |
| Rossmax International Ltd (4121) | $1.85 Billion | -0.36% | 1.21x | $32.33 Million |
| United Orthopedic (4129) | $3.09 Billion | 7.17% | 0.82x | $226.96 Million |
| Dynamic Medical Technologies (4138) | $1.70 Billion | 12.34% | 0.81x | $68.44 Million |
| Ok Biotech Co Ltd (4155) | $303.11 Million | 23.87% | 0.60x | $60.97 Million |
| Bioptik Technology (4161) | $974.69 Million | 7.30% | 0.61x | $39.48 Million |
| AViTA Corporation (4735) | $838.11 Million | 6.91% | 0.42x | $43.13 Million |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more